missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human NHS (aa 1160-1302) Control Fragment Recombinant Protein
Recombinant Protein
Marca: Invitrogen™ RP92106
Este artículo no se puede devolver.
Vea la política de devoluciones
Descripción
Highest antigen sequence indentity to the following orthologs: Mouse (64%), Rat (64%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-56760 (PA5-56760. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
May function in cell morphology by maintaining the integrity of the circumferential actin ring and controlling lamellipod formation. Involved in the regulation eye, tooth, brain and craniofacial development.
Especificaciones
| Q6T4R5 | |
| Blocking Assay, Control | |
| 4810 | |
| 100 μL | |
| congenital cataracts and dental anomalies protein; CTRCT40; CXN; Nance-Horan syndrome (congenital cataracts and dental anomalies); Nance-Horan syndrome protein; NHS; NHS actin remodeling regulator; SCML1 | |
| NHS | |
| Human | |
| His-ABP-tag | |
| -20°C, Avoid Freeze/Thaw Cycles | |
| Liquid |
| ≥5.0 mg/mL | |
| 1 M urea, PBS with no preservative; pH 7.4 | |
| Human NHS (aa 1160-1302) Control Fragment | |
| RUO | |
| NHS | |
| Unconjugated | |
| Recombinant | |
| TDLPYLEESTLTTAALSPSKIRPHTANKSVSRQYSTEDTILSFLDSSAVEMGPDKLHLEKNSTFDVKNRCDPETITSAGSSLLDSNVTKDQVRTETEPIPENTPTKNCAFPTEGFQRVSAARPNDLDGKIIQYGPGPDETLEQ | |
| E. coli | |
| >80% by SDS-PAGE and Coomassie blue staining |
Corrección del contenido de un producto
Proporcione sus comentarios sobre el contenido del producto rellenando el siguiente formulario.
Título del producto
Invitrogen™ Human NHS (aa 1160-1302) Control Fragment Recombinant Protein > 100 μL; Unlabeled
¿Detecta una oportunidad de mejora?Comparta una corrección de contenido